RATIONALE: Considerable evidence indicates that serotonergic (5-HT) mechanisms may mediate central effects of cocaine, and disinhibition and aggression. OBJECTIVE: We investigated whether prolactin (PRL) response to meta-chlorophenylpiperazine (m-CPP), a mixed 5-HT agonist/antagonist, differed between abstinent cocaine-dependent patients and controls and whether m-CPP challenge responses were related to measures of disinhibition and aggression. METHODS: Thirty-five cocaine-dependent African-American subjects who were abstinent for at least 2 weeks and 33 African-American controls underwent assessments of disinhibition and aggression and a challenge with 0.5 mg/kg of oral m-CPP. RESULTS: The PRL response to m-CPP was compared between cocaine patients and controls and between subgroups categorized high or low based on disinhibition and aggression measures. Hierarchical regressions were used to determine whether behavioral measures predicted deltaPRL (peak PRL-baseline PRL). The PRL response to m-CPP was significantly diminished in cocaine patients compared to controls. The blunting was more robust in cocaine patients with high disinhibition and aggression. Among cocaine patients, the high-disinhibition subgroup showed greater blunting than the low-disinhibition subgroup and there was a trend for the high-aggression subgroup to be more blunted than the low-aggression subgroup. The subgroups of controls did not differ from each other. A combination of disinhibition and aggression measures significantly predicted deltaPRL in cocaine patients. CONCLUSION: The results indicate that cocaine-dependent patients show disturbances in postsynaptic 5-HT function during early abstinence. It appears that the 5-HT disturbances are more pronounced in the subgroup of cocaine patients with high disinhibition and aggression.
RATIONALE: Considerable evidence indicates that serotonergic (5-HT) mechanisms may mediate central effects of cocaine, and disinhibition and aggression. OBJECTIVE: We investigated whether prolactin (PRL) response to meta-chlorophenylpiperazine (m-CPP), a mixed 5-HT agonist/antagonist, differed between abstinent cocaine-dependent patients and controls and whether m-CPP challenge responses were related to measures of disinhibition and aggression. METHODS: Thirty-five cocaine-dependent African-American subjects who were abstinent for at least 2 weeks and 33 African-American controls underwent assessments of disinhibition and aggression and a challenge with 0.5 mg/kg of oral m-CPP. RESULTS: The PRL response to m-CPP was compared between cocainepatients and controls and between subgroups categorized high or low based on disinhibition and aggression measures. Hierarchical regressions were used to determine whether behavioral measures predicted deltaPRL (peak PRL-baseline PRL). The PRL response to m-CPP was significantly diminished in cocainepatients compared to controls. The blunting was more robust in cocainepatients with high disinhibition and aggression. Among cocainepatients, the high-disinhibition subgroup showed greater blunting than the low-disinhibition subgroup and there was a trend for the high-aggression subgroup to be more blunted than the low-aggression subgroup. The subgroups of controls did not differ from each other. A combination of disinhibition and aggression measures significantly predicted deltaPRL in cocainepatients. CONCLUSION: The results indicate that cocaine-dependent patients show disturbances in postsynaptic 5-HT function during early abstinence. It appears that the 5-HT disturbances are more pronounced in the subgroup of cocainepatients with high disinhibition and aggression.
Authors: Ashwin A Patkar; Charles C Thornton; Paolo Mannelli; Kevin P Hill; Edward Gottheil; Michael J Vergare; Stephen P Weinstein Journal: J Addict Dis Date: 2004
Authors: Ashwin A Patkar; Wade H Berrettini; Margret Hoehe; Charles C Thornton; Edward Gottheil; Kevin Hill; Stephen P Weinstein Journal: Psychiatry Res Date: 2002-06-01 Impact factor: 3.222
Authors: Marc N Potenza; Edward S Brodkin; Bao-Zhu Yang; Shari G Birnbaum; Eric J Nestler; Joel Gelernter Journal: Neuropsychopharmacology Date: 2008-01-23 Impact factor: 7.853
Authors: Ashwin A Patkar; Steve Rozen; Paolo Mannelli; Wayne Matson; Chi-Un Pae; K Ranga Krishnan; Rima Kaddurah-Daouk Journal: Psychopharmacology (Berl) Date: 2009-08-01 Impact factor: 4.530
Authors: C E Green; F G Moeller; J M Schmitz; J F Lucke; S D Lane; A C Swann; R E Lasky; J P Carbonari Journal: Am J Drug Alcohol Abuse Date: 2009 Impact factor: 3.829
Authors: N C Anastasio; S Liu; L Maili; S E Swinford; S D Lane; R G Fox; S C Hamon; D A Nielsen; K A Cunningham; F G Moeller Journal: Transl Psychiatry Date: 2014-03-11 Impact factor: 6.222